News & Updates
Filter by Specialty:
Immune-related AEs predict survival in cancer patients on ICI
Developing cutaneous immune-related adverse events (cirAEs) among advanced cancer patients on immune checkpoint inhibitor (ICI) appears to be a sign of longer overall survival, particularly in those with melanoma, suggests a recent study.
Immune-related AEs predict survival in cancer patients on ICI
05 May 2023Fluvoxamine plus budesonide helps prevent severe COVID-19
High-risk outpatients with early-onset COVID-19 who are treated with oral fluvoxamine plus inhaled budesonide have a reduced incidence of severe disease that warrants advanced care, reveals a study.
Fluvoxamine plus budesonide helps prevent severe COVID-19
05 May 2023Surgery, but not chemo, may benefit patients with rare ovarian neoplasms
Good quality surgery conferred a progression-free survival (PFS) benefit for women with ovarian sex cord stromal tumours (SCST) in the first-line setting and on first and second relapse. Chemotherapy, on the other hand, had no impact on survival in the first-line or relapse setting.
Surgery, but not chemo, may benefit patients with rare ovarian neoplasms
05 May 2023Preconception HBV history linked to congenital heart disease risk in offspring
Children born to mothers who had contracted hepatitis B virus (HBV) infection before pregnancy appear to be at increased risk of congenital heart diseases (CHDs), as reported in a study.
Preconception HBV history linked to congenital heart disease risk in offspring
04 May 2023Is hypotension avoidance better than hypertension avoidance in noncardiac surgery?
The incidence of major vascular complications among patients who underwent noncardiac surgery is similar between hypotension- and hypertension-avoidance strategies, reports a study.
Is hypotension avoidance better than hypertension avoidance in noncardiac surgery?
04 May 2023Lower phase angle linked to CKD progression in T2DM
A Singapore study has found a previously overlooked connection between bioelectrical impedance analysis (BIA)-derived lower phase angle and chronic kidney disease (CKD) progression, mediated by matrix metalloproteinase-2 (MMP-2), in patients with type 2 diabetes mellitus (T2DM).